Cargando…

Prevalence of chronic kidney disease in fabry disease patients: Multicenter cross sectional study in Argentina

Nephropathy is one of the major complications of Fabry Disease (FD) and mainly includes reduced glomerular filtration rate (GFR) and proteinuria. Despite the frequency, scarce information exists regarding the frequency of CKD as well as other related complications in FD patients in Argentina. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaurretche, Sebastián, Antongiovanni, Norberto, Perretta, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443960/ https://www.ncbi.nlm.nih.gov/pubmed/28607873 http://dx.doi.org/10.1016/j.ymgmr.2017.05.007

Ejemplares similares

Major Organic Involvement in Women with Fabry Disease in Argentina
por: Perretta, Fernando, et al.
Publicado: (2018)

Early Renal Involvement in a Girl with Classic Fabry Disease
por: Perretta, Fernando, et al.
Publicado: (2017)

Direct Correlation between Age at Diagnosis and Severity of Nephropathy in Fabry Disease Patients
por: Jaurretche, Sebastián P. A., et al.
Publicado: (2019)

Variables Associated with a Urinary MicroRNAs Excretion Profile Indicative of Renal Fibrosis in Fabry Disease Patients
por: Jaurretche, Sebastián, et al.
Publicado: (2019)

Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?
por: Perretta, Fernando, et al.
Publicado: (2023)

Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina
por: Cabrera, Gustavo, et al.
Publicado: (2017)

Screening Fabry’s disease in chronic kidney disease patients not on dialysis: a multicenter study
por: Yeniçerioğlu, Yavuz, et al.
Publicado: (2016)

Fabry disease. A potential pitfall A family with a novel intronic mutation
por: Cabrera, Gustavo, et al.
Publicado: (2018)

Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies
por: Thurberg, Beth L., et al.
Publicado: (2016)

Late onset variants in Fabry disease: Results in high risk population screenings in Argentina
por: Serebrinsky, G., et al.
Publicado: (2015)

Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists
por: Jaurretche, Sebastián, et al.
Publicado: (2022)

High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease
por: Jaurretche, Sebastián, et al.
Publicado: (2019)

Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

Parkinson's disease prevalence in Fabry disease: A survey study
por: Wise, Adina H., et al.
Publicado: (2017)

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study
por: Mallett, Andrew, et al.
Publicado: (2022)

Erratum to: Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

Prevalence of cerebral small vessel disease in a Fabry disease cohort
por: Tapia, Daisy, et al.
Publicado: (2021)

Prevalence of Fabry Disease among Patients with Parkinson's Disease
por: Lackova, Alexandra, et al.
Publicado: (2022)

Prevalence of Raynaud Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry Disease: A Cross-Sectional Study
por: Deshayes, Samuel, et al.
Publicado: (2015)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study
por: Li, Ya, et al.
Publicado: (2016)

Fabry Disease Presenting as End-Stage Kidney Disease
por: Pahl, Madeleine V., et al.
Publicado: (2023)

Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on Dialysis
por: Battaglia, Yuri, et al.
Publicado: (2021)

Prevalence of papillary muscle hypertrophy in fabry disease
por: Cianciulli, Tomás Francisco, et al.
Publicado: (2023)

Quality of life in patients with Fabry’s disease: a cross-sectional study of 86 adults
por: Andonian, Caroline, et al.
Publicado: (2022)

The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia
por: Mallett, Andrew, et al.
Publicado: (2020)

The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study
por: Jiang, Zheng, et al.
Publicado: (2021)

Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study
por: Jahan, Sadia, et al.
Publicado: (2020)

Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020)

Diagnosing Fabry nephropathy: the challenge of multiple kidney disease
por: Esposito, Pasquale, et al.
Publicado: (2023)

Screening of family members of chronic kidney disease patients with Fabry disease mutations: a very important and underrated task
por: Sodré, Luciana Senra de Souza, et al.
Publicado: (2020)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol
por: Battaglia, Yuri, et al.
Publicado: (2023)

Prevalence of Fabry disease-causing variants in the UK Biobank
por: Gilchrist, Mark, et al.
Publicado: (2023)

Dysregulated DNA methylation in the pathogenesis of Fabry disease
por: Shen, Jin-Song, et al.
Publicado: (2022)

Prevalence of Fabry Disease in Patients With Cryptogenic Strokes: A Systematic Review
por: Ortiz, Juan Fernando, et al.
Publicado: (2021)

Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
por: Hamed, Alaa, et al.
Publicado: (2021)

Predicting the prevalence of chronic kidney disease in the English population: a cross-sectional study
por: Kearns, Benjamin, et al.
Publicado: (2013)

Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study
por: Cheng, Yang, et al.
Publicado: (2021)

The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicenter cross-sectional study
por: Wang, Wen-Ling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mc7dko575ugjlkcposfo5vbqh5